Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

EHA 17

8 Dec 2011
National Cancer Centre Singapore, Singapore, Singapore
Strategies to improve the tolerability of treatment in patients with multiple my...
Prof Michel Delforge - Catholic University, Leuven, Belgium
Strategies to improve the tolerability of treatment in patients with multiple myeloma ( Prof Michel Delforge - Catholic University, Leuven, Belgium )
13 Jul 2012
Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012
Prof Thierry Facon - Centre Hospitalier Universitaire, France, Prof Pieter Sonne...
Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012 ( Prof Thierry Facon - Centre Hospitalier Universitaire, France, Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands, )
13 Jul 2012
Best treatment for chronic lymphocytic leukaemia with 17p deletion
Prof Michael Keating - MD Anderson Cancer Center, Houston, USA
Best treatment for chronic lymphocytic leukaemia with 17p deletion ( Prof Michael Keating - MD Anderson Cancer Center, Houston, USA )
12 Jul 2012
The involvement of rare cancer patients in clinical research
Jan Geissler - Co-founder of CML Advocates Network
The involvement of rare cancer patients in clinical research ( Jan Geissler - Co-founder of CML Advocates Network )
12 Jul 2012
New drugs on the CML horizon; choosing the correct therapies
Jan Geissler - Co-founder of CML Advocates Network, Prof Giuseppe Saglio - Unive...
New drugs on the CML horizon; choosing the correct therapies ( Jan Geissler - Co-founder of CML Advocates Network, Prof Giuseppe Saglio - University of Turin, Italy, Dr Delphine Rea - Saint Louis Hospital, France )
5 Jul 2012
The evolving landscape in the management of CML
Jan Geissler - Co-founder of CML Advocates Network, Prof Giuseppe Saglio - Unive...
The evolving landscape in the management of CML ( Jan Geissler - Co-founder of CML Advocates Network, Prof Giuseppe Saglio - University of Turin, Italy, Dr Delphine Rea - Saint Louis Hospital, France )
5 Jul 2012
Maintenance therapy in multiple myeloma; the way forward
Prof Gareth Morgan - The Royal Marsden Hospital, London, Prof Antonio Palumbo - ...
Maintenance therapy in multiple myeloma; the way forward ( Prof Gareth Morgan - The Royal Marsden Hospital, London, Prof Antonio Palumbo - University Hospital of Torino, Italy, Dr Paul Richardson - Dana-Farber Cancer Institute, USA )
4 Jul 2012
A new treatment paradigm in multiple myeloma
Prof Gareth Morgan - The Royal Marsden Hospital, London, Prof Antonio Palumbo - ...
A new treatment paradigm in multiple myeloma ( Prof Gareth Morgan - The Royal Marsden Hospital, London, Prof Antonio Palumbo - University Hospital of Torino, Italy, Dr Paul Richardson - Dana-Farber Cancer Institute, USA )
4 Jul 2012
Advances with bendamustine in multiple myeloma from EHA 2012
Prof Philippe Rodon - General Hospital, Blois, France
Advances with bendamustine in multiple myeloma from EHA 2012 ( Prof Philippe Rodon - General Hospital, Blois, France )
4 Jul 2012
Advances in multiple myeloma from EHA 2012
Prof Meletios Dimopoulos - Univeristy of Athens, Greece
Advances in multiple myeloma from EHA 2012 ( Prof Meletios Dimopoulos - Univeristy of Athens, Greece )
4 Jul 2012
Advances in multiple myeloma from EHA 2012; bortezomib and beyond
Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienn...
Advances in multiple myeloma from EHA 2012; bortezomib and beyond ( Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria )
4 Jul 2012
Dasatinib vs. imatinib first-line in CML; new study data
Prof Giuseppe Saglio - University of Turin, Italy
Dasatinib vs. imatinib first-line in CML; new study data ( Prof Giuseppe Saglio - University of Turin, Italy )
4 Jul 2012
The evolving landscape in CML management
Dr Delphine Rea - Saint Louis Hospital, Paris
The evolving landscape in CML management ( Dr Delphine Rea - Saint Louis Hospital, Paris )
4 Jul 2012
AZA in MDS, and managing the older MDS patient
Prof Valeria Santini – University of Florence, Italy
AZA in MDS, and managing the older MDS patient  ( Prof Valeria Santini – University of Florence, Italy )
4 Jul 2012
Lenalidomide in low-risk MDS del(5q)
Prof Aristoteles Giagounidis - St. John’s Hospital, Duisburg, Germany
Lenalidomide in low-risk MDS del(5q) ( Prof Aristoteles Giagounidis - St. John’s Hospital, Duisburg, Germany )
4 Jul 2012
EHA 2012 advances in lymphoma; lenalidamide and beyond
Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Gilles Sall...
EHA 2012 advances in lymphoma; lenalidamide and beyond ( Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Gilles Salles - Universite Claude Bernard, Lyon, France )
29 Jun 2012
Identifying drug sensitivity and resistance in acute myeloid leukaemia
Dr Mark Frattini – Memorial Sloan-Kettering Cancer Center, New York, USA
Identifying drug sensitivity and resistance in acute myeloid leukaemia  ( Dr Mark Frattini – Memorial Sloan-Kettering Cancer Center, New York, USA )
27 Jun 2012
Addressing the problem of adherence to treatment
Giora Sharf – Israeli CML Patients Support Group
Addressing the problem of adherence to treatment ( Giora Sharf – Israeli CML Patients Support Group )
27 Jun 2012
Patient and doctor communication and quality of life guidelines
Jan Geissler – CML Advocates Network
Patient and doctor communication and quality of life guidelines ( Jan Geissler – CML Advocates Network  )
27 Jun 2012
GFI is crucial for AML1-ETO induced acute myeloid leukemia
Dr Bert van der Reijden – Radboud University Nijmegen Medical Centre, Holland
GFI is crucial for AML1-ETO induced acute myeloid leukemia ( Dr Bert van der Reijden – Radboud University Nijmegen Medical Centre, Holland )
26 Jun 2012
Signaling and targeting cellular pathways in leukaemia metabolism
Dr Jing Chen – Emory University School of Medicine, Atlanta, USA
Signaling and targeting cellular pathways in leukaemia metabolism ( Dr Jing Chen – Emory University School of Medicine, Atlanta, USA )
26 Jun 2012
Whole genome sequence analysis for acute lymphoblastic leukaemia
Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA
Whole genome sequence analysis for acute lymphoblastic leukaemia ( Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA )
26 Jun 2012
Use of mesenchymal stromal cells against graft-versus-host disease
Prof Willem Fibbe – Lieden University Medical Center, Holland
Use of mesenchymal stromal cells against graft-versus-host disease (  Prof Willem Fibbe – Lieden University Medical Center, Holland )
26 Jun 2012
Next generation sequencing and the monoclonal structure of multiple myeloma
Dr Niccolo Bolli – University of Cambridge, UK
Next generation sequencing and the monoclonal structure of multiple myeloma ( Dr Niccolo Bolli – University of Cambridge, UK )
26 Jun 2012
Mouse models and proteomics tackling acute lymphoblastic leukaemia
Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland
Mouse models and proteomics tackling acute lymphoblastic leukaemia ( Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland )
25 Jun 2012
Assessing iron overload and toxicity
Prof John Porter - University College London, UK
Assessing iron overload and toxicity ( Prof John Porter - University College London, UK )
25 Jun 2012
What clinicians believe they said and what patients believe they heard
Dr Steve Johnson - Yeovil District Hospital, UK
What clinicians believe they said and what patients believe they heard  ( Dr Steve Johnson - Yeovil District Hospital, UK )
22 Jun 2012
New drugs for relapsed and refractory Hodgkin's lymphoma
Prof Anas Younes - MD Anderson Cancer Center, Houston, USA
New drugs for relapsed and refractory Hodgkin's lymphoma ( Prof Anas Younes - MD Anderson Cancer Center, Houston, USA )
22 Jun 2012
Open Window project improves patient quality of life
Dr Shaun McCann - St James's Hospital, Dublin, Ireland
Open Window project improves patient quality of life ( Dr Shaun McCann - St James's Hospital, Dublin, Ireland )
22 Jun 2012
How malignant cells in patients with CLL escape T-cell recognition
Dr Alan G Ramsay - Barts Cancer Institute, Queen Mary University of London, UK
How malignant cells in patients with CLL escape T-cell recognition ( Dr Alan G Ramsay - Barts Cancer Institute, Queen Mary University of London, UK )
22 Jun 2012
Reducing radiotherapy for Hodgkin's lymphoma while maintaining the highest cure ...
Prof Andreas Engert - University Hospital of Cologne, Germany
Reducing radiotherapy for Hodgkin's lymphoma while maintaining the highest cure rate ( Prof Andreas Engert - University Hospital of Cologne, Germany )
22 Jun 2012
Impressive results with a bispecific antibody for ALL
Prof Max Topp - University of Wuerzberg, Germany
Impressive results with a bispecific antibody for ALL ( Prof Max Topp - University of Wuerzberg, Germany )
21 Jun 2012
Open Window project improves patient quality of life
Dr Shaun McCann - St James's Hospital, Dublin, Ireland
Open Window project improves patient quality of life ( Dr Shaun McCann - St James's Hospital, Dublin, Ireland )
15 Jun 2012
Acute Lymphocytic Leukemia: impressive results with a bispecific antibody in pat...
Prof Max Topp - University of Wuerzberg, Germany
Acute Lymphocytic Leukemia: impressive results with a bispecific antibody in patients with refractory disease ( Prof Max Topp - University of Wuerzberg, Germany )
15 Jun 2012
How malignant cells in patients with CLL escape T-cell recognition
Dr Alan G Ramsay - Barts Cancer Institute, Queen Mary University of London, UK
How malignant cells in patients with CLL escape T-cell recognition ( Dr Alan G Ramsay - Barts Cancer Institute, Queen Mary University of London, UK )
15 Jun 2012
Hodgkin Lymphoma focusing on reducing radiotherapy, while maintaining the highes...
Prof Andreas Engert - University Hospital of Cologne, Germany
Hodgkin Lymphoma focusing on reducing radiotherapy, while maintaining the highest possible cure rate ( Prof Andreas Engert - University Hospital of Cologne, Germany )
13 Jun 2012